1947 related articles for article (PubMed ID: 33278357)
1. Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.
Karki R; Sharma BR; Tuladhar S; Williams EP; Zalduondo L; Samir P; Zheng M; Sundaram B; Banoth B; Malireddi RKS; Schreiner P; Neale G; Vogel P; Webby R; Jonsson CB; Kanneganti TD
Cell; 2021 Jan; 184(1):149-168.e17. PubMed ID: 33278357
[TBL] [Abstract][Full Text] [Related]
2. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes.
Karki R; Sharma BR; Tuladhar S; Williams EP; Zalduondo L; Samir P; Zheng M; Sundaram B; Banoth B; Malireddi RKS; Schreiner P; Neale G; Vogel P; Webby R; Jonsson CB; Kanneganti TD
bioRxiv; 2020 Nov; ():. PubMed ID: 33140051
[TBL] [Abstract][Full Text] [Related]
3. Helminth alleviates COVID-19-related cytokine storm in an IL-9-dependent way.
Cao Z; Wang J; Liu X; Liu Y; Li F; Liu M; Chiu S; Jin X
mBio; 2024 Jun; 15(6):e0090524. PubMed ID: 38727220
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
[TBL] [Abstract][Full Text] [Related]
6. Synergism of TNF-α and IFN-β triggers human airway epithelial cells death by apoptosis and pyroptosis.
Sun R; Jiang K; Zeng C; Zhu R; Chu H; Liu H; Du J
Mol Immunol; 2023 Jan; 153():160-169. PubMed ID: 36508750
[TBL] [Abstract][Full Text] [Related]
7. TNF-α/IFN-γ synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK/STAT1.
Kandhaya-Pillai R; Yang X; Tchkonia T; Martin GM; Kirkland JL; Oshima J
Aging Cell; 2022 Jun; 21(6):e13646. PubMed ID: 35645319
[TBL] [Abstract][Full Text] [Related]
8. Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.
Gu T; Zhao S; Jin G; Song M; Zhi Y; Zhao R; Ma F; Zheng Y; Wang K; Liu H; Xin M; Han W; Li X; Dong CD; Liu K; Dong Z
Front Immunol; 2020; 11():621441. PubMed ID: 33584719
[TBL] [Abstract][Full Text] [Related]
9. Innate immunity, cytokine storm, and inflammatory cell death in COVID-19.
Karki R; Kanneganti TD
J Transl Med; 2022 Nov; 20(1):542. PubMed ID: 36419185
[TBL] [Abstract][Full Text] [Related]
10. Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection.
Solimani F; Meier K; Ghoreschi K
Eur J Immunol; 2021 May; 51(5):1071-1075. PubMed ID: 33675065
[TBL] [Abstract][Full Text] [Related]
11. "Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-γ, IL-17A, and a Janus Kinase Inhibitor.
Kale SD; Mehrkens BN; Stegman MM; Kastelberg B; Carnes H; McNeill RJ; Rizzo A; Karyala SV; Coutermarsh-Ott S; Fretz JA; Sun Y; Koff JL; Rajagopalan G
Front Immunol; 2020; 11():1311. PubMed ID: 32676080
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Cell Death, PANoptosis, Mediated by Cytokines in Diverse Cancer Lineages Inhibits Tumor Growth.
Malireddi RKS; Karki R; Sundaram B; Kancharana B; Lee S; Samir P; Kanneganti TD
Immunohorizons; 2021 Jul; 5(7):568-580. PubMed ID: 34290111
[TBL] [Abstract][Full Text] [Related]
13. ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection.
Karki R; Lee S; Mall R; Pandian N; Wang Y; Sharma BR; Malireddi RS; Yang D; Trifkovic S; Steele JA; Connelly JP; Vishwanath G; Sasikala M; Reddy DN; Vogel P; Pruett-Miller SM; Webby R; Jonsson CB; Kanneganti TD
Sci Immunol; 2022 Aug; 7(74):eabo6294. PubMed ID: 35587515
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 patients with high TNF/IFN-γ levels show hallmarks of PANoptosis, an inflammatory cell death.
Palacios Y; Ramón-Luing LA; Ruiz A; García-Martínez A; Sánchez-Monciváis A; Barreto-Rodríguez O; Falfán-Valencia R; Pérez-Rubio G; Medina-Quero K; Buendia-Roldan I; Chavez-Galan L
Microbes Infect; 2023; 25(8):105179. PubMed ID: 37394112
[TBL] [Abstract][Full Text] [Related]
15. Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology.
Suárez-Reyes A; Villegas-Valverde CA
MEDICC Rev; 2021 Apr; 23(2):42. PubMed ID: 33974614
[TBL] [Abstract][Full Text] [Related]
16. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.
Remy KE; Mazer M; Striker DA; Ellebedy AH; Walton AH; Unsinger J; Blood TM; Mudd PA; Yi DJ; Mannion DA; Osborne DF; Martin RS; Anand NJ; Bosanquet JP; Blood J; Drewry AM; Caldwell CC; Turnbull IR; Brakenridge SC; Moldwawer LL; Hotchkiss RS
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32687484
[TBL] [Abstract][Full Text] [Related]
17. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
18. Inflammation Unrestrained by SIRPα Induces Secondary Hemophagocytic Lymphohistiocytosis Independent of IFN-γ.
Kidder K; Bian Z; Shi L; Liu Y
J Immunol; 2020 Nov; 205(10):2821-2833. PubMed ID: 33028619
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.
Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS
J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704
[TBL] [Abstract][Full Text] [Related]
20. Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19.
Paolini A; Borella R; De Biasi S; Neroni A; Mattioli M; Lo Tartaro D; Simonini C; Franceschini L; Cicco G; Piparo AM; Cossarizza A; Gibellini L
Cells; 2021 Jun; 10(7):. PubMed ID: 34201847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
